Antibody cross-competition analysis of the human immunodeficiency virus type 1 gp120 exterior envelope glycoprotein

Area of Science:

• Virology
• Immunology
• Structural Biology

Background:

• The human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein, gp120, is a key target for antibody-mediated neutralization.
• Understanding the structural organization of gp120 epitopes is crucial for developing effective HIV-1 vaccines and therapies.

Purpose of the Study:

• To delineate distinct functional faces of the native, monomeric HIV-1 gp120 glycoprotein.
• To map the locations of binding sites for the viral receptor CD4 and various monoclonal antibodies (MAbs).

Main Methods:

• Generation of a competition-binding matrix using 46 monoclonal antibodies (MAbs) against the HIV-1 LAI (HXBc2) strain gp120.
• Analysis of antibody binding patterns to infer epitope locations and accessibility.

Main Results:

• The study identified two distinct faces on the gp120 glycoprotein.
• One face contains binding sites for CD4 and neutralizing MAbs, likely accessible on the assembled viral envelope.
• A second, presumably inaccessible face, harbors epitopes recognized by nonneutralizing antibodies.

Conclusions:

• The findings provide a structural model for gp120-antibody interactions.
• This understanding is valuable for designing immunogens and therapeutic antibodies targeting HIV-1.
• The identified epitope distribution aids in comprehending HIV-1 neutralization mechanisms.